Zoetis (ZTS) Revenue — Quarter Ended Dec 31, 2023
Revenue increased in the latest quarter compared to both the prior quarter and the same period last year. The filing attributes the rise in accounts receivable to higher net sales, supporting the reported revenue growth.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue increased in the latest quarter compared to both the prior quarter and the same period last year. The filing attributes the rise in accounts receivable to higher net sales, supporting the reported revenue growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.2B
Revenue reported for this quarter.
Quarter-over-quarter
+2.9%
Change from the immediately preceding quarter.
Year-over-year
+8.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$8.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $2B | +0.7% |
| Jun 30, 2023 | $2.2B | +6.2% |
| Sep 30, 2023 | $2.2B | +7.4% |
| Dec 31, 2023 | $2.2B | +8.5% |
Revenue performance
Relative to the immediately preceding quarter, revenue grew. The year-over-year comparison shows a stronger increase than the sequential change.
Quarterly comparison
The increase in accounts receivable was linked to higher net sales, consistent with the reported revenue. Inventories rose to support production for anticipated demand, including new product launches.
What to watch
The inventory buildup for new product launches should be monitored for its impact on future revenue.